893566-72-8,MFCD11044669
Catalog No.:AA0086DK

893566-72-8 | tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1h)-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$12.00   $8.00
- +
250mg
98%
in stock  
$21.00   $15.00
- +
1g
98%
in stock  
$81.00   $57.00
- +
5g
98%
in stock  
$400.00   $280.00
- +
25g
98%
in stock  
$1,804.00   $1,263.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0086DK
Chemical Name:
tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1h)-carboxylate
CAS Number:
893566-72-8
Molecular Formula:
C20H30BNO4
Molecular Weight:
359.2675
MDL Number:
MFCD11044669
SMILES:
O=C(N1CCc2c(C1)ccc(c2)B1OC(C(O1)(C)C)(C)C)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
526  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route

[1]Patent:US2008/171754,2008,A1.Locationinpatent:Page/Pagecolumn102

[2]Patent:WO2006/65215,2006,A1.Locationinpatent:Page/Pagecolumn23-24

[3]Patent:WO2006/65216,2006,A1.Locationinpatent:Page/Pagecolumn23

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/65216,2006,A1Locationinpatent:Page/Pagecolumn22-23

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/65215,2006,A1Locationinpatent:Page/Pagecolumn23

[1]CurrentPatentAssignee:CALITORSCIENCESLLC;SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-WO2014/89324,2014,A1Locationinpatent:Paragraph0237;0245

[2]CurrentPatentAssignee:CALITORSCIENCESLLC;SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-CN104016979,2017,BLocationinpatent:Paragraph0637;0638;0639

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2021/87181,2021,A1Locationinpatent:Page/Pagecolumn146-147

[4]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3248968,2017,A1Locationinpatent:Paragraph0141

[5]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2019/152419,2019,A1Locationinpatent:Paragraph0335;0337-0338

[6]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2020/219448,2020,A1Locationinpatent:Paragraph0387-0388

[7]CurrentPatentAssignee:MILAMEDICALSHARELTDCOMPANY;MIRATITHERAPEUTICS,INC.-WO2020/247475,2020,A1Locationinpatent:Paragraph0328-0329

[8]CurrentPatentAssignee:PRAXISBIOTECHLLC-WO2020/132661,2020,A2Locationinpatent:Paragraph0292

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/145202,2010,A1Locationinpatent:Page/Pagecolumn36-37

[10]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/146105,2010,A1Locationinpatent:Page/Pagecolumn94

[11]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2009/87212,2009,A2Locationinpatent:Page/Pagecolumn148

[12]CurrentPatentAssignee:CHEMOCENTRYXINC-US2021/2229,2021,A1Locationinpatent:Paragraph0132;0134

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:893566-72-8 Molecular Formula|893566-72-8 MDL|893566-72-8 SMILES|893566-72-8 tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1h)-carboxylate
Catalog No.: AA0086DK
893566-72-8,MFCD11044669
893566-72-8 | tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1h)-carboxylate
Pack Size: 100mg
Purity: 98%
in stock
$12.00 $8.00
Pack Size: 250mg
Purity: 98%
in stock
$21.00 $15.00
Pack Size: 1g
Purity: 98%
in stock
$81.00 $57.00
Pack Size: 5g
Purity: 98%
in stock
$400.00 $280.00
Pack Size: 25g
Purity: 98%
in stock
$1,804.00 $1,263.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0086DK
Chemical Name: tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1h)-carboxylate
CAS Number: 893566-72-8
Molecular Formula: C20H30BNO4
Molecular Weight: 359.2675
MDL Number: MFCD11044669
SMILES: O=C(N1CCc2c(C1)ccc(c2)B1OC(C(O1)(C)C)(C)C)OC(C)(C)C
Properties
Complexity: 526  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 26  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
893566-75-1    893566-74-0    73183-34-3    893566-72-8    893566-73-9 

[1]Patent:US2008/171754,2008,A1.Locationinpatent:Page/Pagecolumn102

[2]Patent:WO2006/65215,2006,A1.Locationinpatent:Page/Pagecolumn23-24

[3]Patent:WO2006/65216,2006,A1.Locationinpatent:Page/Pagecolumn23

866602-85-9    893566-72-8    893566-73-9    893566-71-7 

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/65216,2006,A1Locationinpatent:Page/Pagecolumn22-23

304902-96-3    893566-72-8    893566-73-9    893567-06-1 

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/65215,2006,A1Locationinpatent:Page/Pagecolumn23

893566-74-0    73183-34-3    893566-72-8 

[1]CurrentPatentAssignee:CALITORSCIENCESLLC;SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-WO2014/89324,2014,A1Locationinpatent:Paragraph0237;0245

[2]CurrentPatentAssignee:CALITORSCIENCESLLC;SHENZHENDONGYANGGUANGINDUSTRIALDEVELOPMENTCOLTD-CN104016979,2017,BLocationinpatent:Paragraph0637;0638;0639

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2021/87181,2021,A1Locationinpatent:Page/Pagecolumn146-147

[4]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3248968,2017,A1Locationinpatent:Paragraph0141

[5]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2019/152419,2019,A1Locationinpatent:Paragraph0335;0337-0338

[6]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2020/219448,2020,A1Locationinpatent:Paragraph0387-0388

[7]CurrentPatentAssignee:MILAMEDICALSHARELTDCOMPANY;MIRATITHERAPEUTICS,INC.-WO2020/247475,2020,A1Locationinpatent:Paragraph0328-0329

[8]CurrentPatentAssignee:PRAXISBIOTECHLLC-WO2020/132661,2020,A2Locationinpatent:Paragraph0292

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/145202,2010,A1Locationinpatent:Page/Pagecolumn36-37

[10]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/146105,2010,A1Locationinpatent:Page/Pagecolumn94

[11]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2009/87212,2009,A2Locationinpatent:Page/Pagecolumn148

[12]CurrentPatentAssignee:CHEMOCENTRYXINC-US2021/2229,2021,A1Locationinpatent:Paragraph0132;0134

Building Blocks More >
890098-04-1
890098-04-1
2-Chloro-2'-methoxybenzophenone
AA0088LQ | MFCD07698786
885272-28-6
885272-28-6
(6-Methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)-acetic acid
AA0089M2 | MFCD06738901
882679-07-4
882679-07-4
Pyrido[2,3-d]pyrimidin-2-amine
AA008AO0 | MFCD11040206
874902-19-9
874902-19-9
LY2183240
AA008C5F | MFCD08703123
880361-71-7
880361-71-7
1-(1-METHYL-1H-IMIDAZOL-2-YLMETHYL)-PIPERAZINE
AA008DH3 | MFCD05864493
86873-62-3
86873-62-3
5-Acetamidopyridine-2-carboxylic acid
AA008EHU | MFCD15475043
871332-80-8
871332-80-8
3-(Morpholine-4-carbonyl)-5-nitrophenylboronic acid
AA008F8J | MFCD08056359
859721-53-2
859721-53-2
4-(4-(Trifluoromethyl)phenyl)oxazol-2-amine
AA008FTT | MFCD14706776
85787-95-7
85787-95-7
8H-Indeno[1,2-d][1,3]thiazol-2-amine
AA008GI1 | MFCD08689683
85612-59-5
85612-59-5
1,2-Propanediamine,3-phenyl-, (2R)-
AA008H7A | MFCD03425626
Submit
© 2017 AA BLOCKS, INC. All rights reserved.